MentionFox
Home › 5%+ stakes › Manufacturing (industry group 38), latest filing in April 2026
5%+ stakes

Manufacturing (industry group 38), latest filing in April 2026

28 companies with 5%+ holders, every filing linked: Agilent Technologies Inc, Alpha Pro Tech Ltd, AMETEK Inc, Applied Energetics, Inc., Avantor Inc, Cognex Corp and more. Each section is the company's full record from its filings, newest filings first within each section.

On this page

Agilent Technologies Inc

At 5% or more2
Filings3
Latest filing2026-04-29

Agilent Technologies Inc has 3 Schedule 13D or 13G filings on record since 2026-03-26. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%21,189,662SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Portfolio Management5.09%14,387,171SCHEDULE 13G, 2026-04-282026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management2,808,632021,189,6620SCHEDULE 13G, 2026-04-29
Vanguard Portfolio Management34,489014,387,1710SCHEDULE 13G, 2026-04-28
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Agilent Technologies Inc by CUSIP 00846U101 and gives its principal executive office as 5301 Stevens Creek Blvd, Santa Clara, CA 95051 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-28Vanguard Portfolio Management5.09%SCHEDULE 13G
2026-04-29Vanguard Capital Management7.49%SCHEDULE 13G
DateRecordFigureOur pageSource
September 8, 2026Leadership change: Boon Hwee Koh departs, Chairperson of the Board, and 1 more—Leadership changesSource
May 27, 2026Leadership change: Tim Downs appointed, Chief Accounting Officer—Leadership changesSource
May 4, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 6, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Alpha Pro Tech Ltd

At 5% or more1
Filings4
Latest filing2026-10-30

Alpha Pro Tech Ltd has 4 Schedule 13D or 13G filings on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Needham Investment Management L.L.C.6.2%642,500SCHEDULE 13G/A, 2026-02-132025-12-31
Vanguard Capital Management4.29%438,457SCHEDULE 13G/A, 2026-10-302026-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Needham Investment Management L.L.C.0642,5000642,500SCHEDULE 13G/A, 2026-02-13
Needham Asset Management, LLC0642,5000642,500SCHEDULE 13G/A, 2026-02-13
Needham Aggressive Growth Fund0642,5000642,500SCHEDULE 13G/A, 2026-02-13
George A. Needham0642,5000642,500SCHEDULE 13G/A, 2026-02-13
Vanguard Capital Management55,7490438,4570SCHEDULE 13G/A, 2026-10-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Alpha Pro Tech Ltd by CUSIP 020772109 and gives its principal executive office as 60 Centurian Drive, Suite 112, Markham (SCHEDULE 13G/A, 2026-10-30).

FiledHolderPercentFiling
2026-02-13Needham Investment Management L.L.C.6.2%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-28Vanguard Capital Management5.97%SCHEDULE 13G
2026-10-30Vanguard Capital Management4.29%SCHEDULE 13G/A

AMETEK Inc

At 5% or more1
Filings2
Latest filing2026-04-29

AMETEK Inc has 2 Schedule 13D or 13G filings on record since 2026-03-26. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%17,175,368SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management2,248,853017,175,3680SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies AMETEK Inc by CUSIP 031100100 and gives its principal executive office as 1100 Cassatt Rd, Berwyn, PA 19312 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.49%SCHEDULE 13G

Applied Energetics, Inc.

At 5% or more1
Filings1
Latest filing2026-04-23

Applied Energetics, Inc. has 1 Schedule 13D or 13G filing on record since 2026-04-23. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Ingalls & Snyder LLC7.7%17,230,596SCHEDULE 13G, 2026-04-232025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Ingalls & Snyder LLC00017,230,596SCHEDULE 13G, 2026-04-23

The latest filing identifies Applied Energetics, Inc. by CUSIP 03819M106 and gives its principal executive office as 9070 S. RITA ROAD, SUITE 1500, TUCSON, AZ 85747 (SCHEDULE 13G, 2026-04-23).

FiledHolderPercentFiling
2026-04-23Ingalls & Snyder LLC7.7%SCHEDULE 13G

Avantor Inc

At 5% or more3
Filings6
Latest filing2026-04-29

Avantor Inc has 6 Schedule 13D or 13G filings on record since 2025-08-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dodge & Cox17.2%117,433,484SCHEDULE 13G/A, 2025-08-132025-06-30
BlackRock, Inc.8.7%59,049,575SCHEDULE 13G/A, 2025-10-172025-09-30
Vanguard Capital Management5.29%35,802,263SCHEDULE 13G, 2026-04-292026-03-31
T. Rowe Price Investment Management, Inc.4.8%32,928,415SCHEDULE 13G/A, 2025-11-142025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.56,188,076059,049,5750SCHEDULE 13G/A, 2025-10-17
Vanguard Capital Management5,196,151035,802,2630SCHEDULE 13G, 2026-04-29
T. Rowe Price Investment Management, Inc.32,838,902032,928,4150SCHEDULE 13G/A, 2025-11-14
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Avantor Inc by CUSIP 05352A100 and gives its principal executive office as Radnor Corporate Center Bldg 1, Ste 200, Radnor, PA 19087 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-08-13Dodge & Cox17.2%SCHEDULE 13G/A
2025-08-14T. Rowe Price Investment Management, Inc.8.3%SCHEDULE 13G/A
2025-10-17BlackRock, Inc.8.7%SCHEDULE 13G/A
2025-11-14T. Rowe Price Investment Management, Inc.4.8%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.29%SCHEDULE 13G
DateRecordFigureOur pageSource
September 21, 2026Leadership change: Todd Garner appointed—Leadership changesSource
September 21, 2026Leadership change: Todd Garner appointed—Leadership changesSource
August 27, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 23, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 1, 2026Leadership change: R. Brent Jones departs, Chief Financial Officer—Leadership changesSource

Cognex Corp

At 5% or more2
Filings4
Latest filing2026-04-29

Cognex Corp has 4 Schedule 13D or 13G filings on record since 2025-10-30. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Portfolio Management6.22%10,390,950SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.21%8,705,689SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management20,303010,390,9500SCHEDULE 13G, 2026-04-29
Vanguard Capital Management1,275,53308,705,6890SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Cognex Corp by CUSIP 192422103 and gives its principal executive office as 1 Vision Drive, Natick, MA 01760 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-10-30The Vanguard Group11.07%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.21%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management6.22%SCHEDULE 13G

CONMED Corp

At 5% or more4
Filings6
Latest filing2026-04-29

CONMED Corp has 6 Schedule 13D or 13G filings on record since 2025-07-18. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.15.1%4,679,441SCHEDULE 13G/A, 2025-07-182025-06-30
Vanguard Portfolio Management6.87%2,120,886SCHEDULE 13G, 2026-04-292026-03-31
Fuller & Thaler Asset Management, Inc.5.63%1,740,630SCHEDULE 13G, 2025-08-142025-06-30
Vanguard Capital Management5.25%1,619,070SCHEDULE 13G, 2026-04-292026-03-31
Capital Research Global Investors3.3%1,032,733SCHEDULE 13G/A, 2025-11-132025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management44,46902,120,8860SCHEDULE 13G, 2026-04-29
Vanguard Capital Management235,02801,619,0700SCHEDULE 13G, 2026-04-29
Capital Research Global Investors1,032,73301,032,7330SCHEDULE 13G/A, 2025-11-13
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies CONMED Corp by CUSIP 207410101 and gives its principal executive office as 525 French Road, New York, NY 13502 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-07-18BlackRock, Inc.15.1%SCHEDULE 13G/A
2025-08-14Fuller & Thaler Asset Management, Inc.5.63%SCHEDULE 13G
2025-11-13Capital Research Global Investors3.3%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.25%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management6.87%SCHEDULE 13G
DateRecordFigureOur pageSource
June 17, 2026Leadership change: John E. Gallagher appointed, Chief Financial Officer—Leadership changesSource
May 20, 2026Leadership change: Celine Martin appointed, Director, and 2 more—Leadership changesSource

Danaher Corp

At 5% or more1
Filings3
Latest filing2026-04-29

Danaher Corp has 3 Schedule 13D or 13G filings on record since 2026-01-30. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management6.69%47,383,707SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management6,255,897047,383,7070SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Danaher Corp by CUSIP 235851102 and gives its principal executive office as 2200 Pennsylvania Avenue, Northwest, Washington, DC 20037 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2026-01-30The Vanguard Group8.63%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management6.69%SCHEDULE 13G
DateRecordFigureOur pageSource
October 13, 2026Leadership change: Daniel L. Comas appointed, and 1 more—Leadership changesSource
August 3, 2026Leadership change: Rainer M. Blair appointed—Leadership changesSource

Dexcom Inc

At 5% or more2
Filings4
Latest filing2026-04-29

Dexcom Inc has 4 Schedule 13D or 13G filings on record since 2025-10-30. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%28,848,218SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Portfolio Management5.02%19,322,566SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management3,827,257028,848,2180SCHEDULE 13G, 2026-04-29
Vanguard Portfolio Management102,613019,322,5660SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Dexcom Inc by CUSIP 252131107 and gives its principal executive office as 6340 Sequence Drive, San Diego, CA 92121 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-10-30The Vanguard Group12.61%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.49%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.02%SCHEDULE 13G
DateRecordFigureOur pageSource
September 14, 2026Leadership change: Jereme Sylvain appointed, Chief Financial Officer—Leadership changesSource
September 10, 2026Leadership change: Glenn S. Boehnlein appointed, Director, and 1 more—Leadership changesSource

Edwards Lifesciences Corp

At 5% or more2
Filings4
Latest filing2026-04-29

Edwards Lifesciences Corp has 4 Schedule 13D or 13G filings on record since 2025-08-12. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.54%43,477,533SCHEDULE 13G, 2026-04-292026-03-31
BlackRock, Inc.7.5%44,267,376SCHEDULE 13G/A, 2025-10-172025-09-30
Wellington Management Group LLP3.4%19,826,483SCHEDULE 13G/A, 2025-08-122025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management5,749,741043,477,5330SCHEDULE 13G, 2026-04-29
BlackRock, Inc.40,035,206044,267,3760SCHEDULE 13G/A, 2025-10-17
Wellington Management Group LLP018,601,111019,826,483SCHEDULE 13G/A, 2025-08-12
Wellington Group Holdings LLP018,601,111019,826,483SCHEDULE 13G/A, 2025-08-12
Wellington Investment Advisors Holdings LLP018,601,111019,826,483SCHEDULE 13G/A, 2025-08-12
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Edwards Lifesciences Corp by CUSIP 28176E108 and gives its principal executive office as 1 Edwards Way, Irvine, CA 92614 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-08-12Wellington Management Group LLP3.4%SCHEDULE 13G/A
2025-10-17BlackRock, Inc.7.5%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management7.54%SCHEDULE 13G
DateRecordFigureOur pageSource
August 28, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 4, 2026Leadership change: Theodora Mistras appointed, Chief Financial Officer—Leadership changesSource

Escalon Medical Corp.

At 5% or more1
Filings3
Latest filing2026-04-09

Escalon Medical Corp. has 3 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
LPL Financial LLC7.9%586,749SCHEDULE 13G, 2026-04-092026-03-31
Newton Charles Carter0%0SCHEDULE 13G/A, 2025-10-062025-10-06
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
LPL Financial LLC000586,749SCHEDULE 13G, 2026-04-09
Newton Charles Carter0000SCHEDULE 13G/A, 2025-10-06

The latest filing identifies Escalon Medical Corp. by CUSIP 296074305 and gives its principal executive office as 435 Devon Park Drive, Suite 824, Wayne, PA 19087 (SCHEDULE 13G, 2026-04-09).

The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G. Percentage ownership is based on 7,415,329 shares of Common Stock outstanding as of February 13, 2026, as reported in the Issuer's Report on Form 10-Q for the period ended December 31, 2025 filed with the Securities and Exchange Commission on February 17, 2026.LPL Financial LLC, SCHEDULE 13G, 2026-04-09
FiledHolderPercentFiling
2025-07-08Newton Charles Carter6.3%SCHEDULE 13G/A
2025-10-06Newton Charles Carter0%SCHEDULE 13G/A
2026-04-09LPL Financial LLC7.9%SCHEDULE 13G

Hologic Inc

At 5% or more1
Filings5
Latest filing2026-04-30

Hologic Inc has 5 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%16,721,923SCHEDULE 13G, 2026-04-302026-03-31
T. Rowe Price Investment Management, Inc.2.7%5,932,301SCHEDULE 13G/A, 2026-02-172025-12-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management2,218,009016,721,9230SCHEDULE 13G, 2026-04-30
T. Rowe Price Investment Management, Inc.5,914,77305,932,3010SCHEDULE 13G/A, 2026-02-17
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Hologic Inc by CUSIP 436440101 and gives its principal executive office as 250 Campus Drive, Marlborough, MA 01752 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-07-08T. Rowe Price Investment Management, Inc.10.8%SCHEDULE 13G/A
2025-11-14T. Rowe Price Investment Management, Inc.9.7%SCHEDULE 13G/A
2026-02-17T. Rowe Price Investment Management, Inc.2.7%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G
DateRecordFigureOur pageSource
April 7, 2026Acquired by Hopper Parent Inc.—AcquisitionSource
April 7, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 6, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Intuitive Surgical Inc

At 5% or more1
Filings2
Latest filing2026-04-30

Intuitive Surgical Inc has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%26,601,419SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management3,521,929026,601,4190SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Intuitive Surgical Inc by CUSIP 46120E602 and gives its principal executive office as 1020 Kifer Rd, Sunnyvale, CA 94086 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G
DateRecordFigureOur pageSource
November 2, 2026Leadership change: Aaron Martin appointed—Leadership changesSource
May 28, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Itron Inc

At 5% or more2
Filings4
Latest filing2026-04-30

Itron Inc has 4 Schedule 13D or 13G filings on record since 2025-11-06. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Portfolio Management7.97%3,534,821SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.33%2,362,484SCHEDULE 13G, 2026-04-302026-03-31
Invesco Ltd.4.9%2,263,698SCHEDULE 13G/A, 2025-11-062025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management28,15403,534,8210SCHEDULE 13G, 2026-04-29
Vanguard Capital Management348,36402,362,4840SCHEDULE 13G, 2026-04-30
Invesco Ltd.2,170,01302,263,6980SCHEDULE 13G/A, 2025-11-06
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Itron Inc by CUSIP 465741106 and gives its principal executive office as 2111 North Molter Road, Liberty Lake, WA 99019 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-11-06Invesco Ltd.4.9%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management7.97%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.33%SCHEDULE 13G

KLA Corp

At 5% or more1
Filings2
Latest filing2026-04-30

KLA Corp has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.49%9,822,421SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management1,303,04709,822,4210SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies KLA Corp by CUSIP 482480100 and gives its principal executive office as One Technology Drive, Milpitas, CA 95035 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G

Medtronic PLC

At 5% or more1
Filings3
Latest filing2026-04-28

Medtronic PLC has 3 Schedule 13D or 13G filings on record since 2025-12-03. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.51%96,424,044SCHEDULE 13G, 2026-04-282026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management13,090,211096,424,0440SCHEDULE 13G, 2026-04-28
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Medtronic PLC by CUSIP G5960L103 and gives its principal executive office as BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY (SCHEDULE 13G, 2026-04-28).

FiledHolderPercentFiling
2025-12-03The Vanguard Group10.21%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-28Vanguard Capital Management7.51%SCHEDULE 13G
DateRecordFigureOur pageSource
October 19, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 18, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Merit Medical Systems Inc

At 5% or more3
Filings4
Latest filing2026-04-30

Merit Medical Systems Inc has 4 Schedule 13D or 13G filings on record since 2025-10-17. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.14.1%8,370,301SCHEDULE 13G/A, 2025-10-172025-09-30
Vanguard Portfolio Management6.01%3,571,916SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.23%3,109,720SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.8,266,30608,370,3010SCHEDULE 13G/A, 2025-10-17
Vanguard Portfolio Management48,82803,571,9160SCHEDULE 13G, 2026-04-29
Vanguard Capital Management453,55703,109,7200SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Merit Medical Systems Inc by CUSIP 589889104 and gives its principal executive office as 1600 West Merit Parkway, South Jordan, UT 84095 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-10-17BlackRock, Inc.14.1%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management6.01%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.23%SCHEDULE 13G
DateRecordFigureOur pageSource
August 20, 2026Leadership change: Sheri Lewis appointed, Executive Vice President—Leadership changesSource

Mirion Technologies Inc

At 5% or more4
Filings7
Latest filing2026-04-30

Mirion Technologies Inc has 7 Schedule 13D or 13G filings on record since 2025-10-02. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.14.8%35,690,382SCHEDULE 13G/A, 2025-10-022025-09-30
Vanguard Portfolio Management7.4%18,118,998SCHEDULE 13G, 2026-04-292026-03-31
T. Rowe Price Investment Management, Inc.6.1%15,112,855SCHEDULE 13G/A, 2026-02-172025-12-31
Vanguard Capital Management5.03%12,327,150SCHEDULE 13G, 2026-04-302026-03-31
Kuwait Investment Authority, acting for and on behalf of the Government of the State of Kuwait (KIA)4.1%10,171,591SCHEDULE 13G/A, 2026-01-212022-07-29
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management213,276018,118,9980SCHEDULE 13G, 2026-04-29
T. Rowe Price Investment Management, Inc.15,076,254015,112,8550SCHEDULE 13G/A, 2026-02-17
Vanguard Capital Management1,821,955012,327,1500SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Mirion Technologies Inc by CUSIP 60471A101 and gives its principal executive office as 1218 Menlo Drive, Atlanta, GA 30318 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-10-02BlackRock, Inc.14.8%SCHEDULE 13G/A
2025-10-31The Vanguard Group12.45%SCHEDULE 13G/A
2026-01-21Kuwait Investment Authority, acting for and on behalf of the Government of the State of Kuwait (KIA)4.1%SCHEDULE 13G/A
2026-02-17T. Rowe Price Investment Management, Inc.6.1%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management7.4%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.03%SCHEDULE 13G
DateRecordFigureOur pageSource
July 2, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

MSA Safety Inc

At 5% or more1
Filings3
Latest filing2026-04-30

MSA Safety Inc has 3 Schedule 13D or 13G filings on record since 2025-07-31. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management5.12%1,985,590SCHEDULE 13G, 2026-04-302026-03-31
Jpmorgan Chase & Co.4.6%1,808,296SCHEDULE 13G/A, 2025-07-312025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management281,80701,985,5900SCHEDULE 13G, 2026-04-30
Jpmorgan Chase & Co.1,665,71411,807,219815SCHEDULE 13G/A, 2025-07-31
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies MSA Safety Inc by CUSIP 553498106 and gives its principal executive office as 1000 Cranberry Woods Drive, Cranberry Township, PA 16066 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-07-31Jpmorgan Chase & Co.4.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management5.12%SCHEDULE 13G

Nexgel, Inc.

At 5% or more1
Filings2
Latest filing2026-04-29

Nexgel, Inc. has 2 Schedule 13D or 13G filings on record since 2026-03-12. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Asymmetry Point LP8.8%745,000SCHEDULE 13G/A, 2026-04-292026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Asymmetry Point LP745,0000745,0000SCHEDULE 13G/A, 2026-04-29
Asymmetry Point Capital LLC745,0000745,0000SCHEDULE 13G/A, 2026-04-29
Mr. Aviv Argaman745,0000745,0000SCHEDULE 13G/A, 2026-04-29

The latest filing identifies Nexgel, Inc. by CUSIP 65344E107 and gives its principal executive office as 2150 CABOT BLVD WEST, Suite B, LANGHORNE, PA 19047 (SCHEDULE 13G/A, 2026-04-29).

FiledHolderPercentFiling
2026-03-12Asymmetry Point LP7.49%SCHEDULE 13G
2026-04-29Asymmetry Point LP8.8%SCHEDULE 13G/A
DateRecordFigureOur pageSource
August 21, 2026Leadership change: Brian Kieser appointed, Chief Executive Officer—Leadership changesSource
July 2, 2026Leadership change: Scott Henry departs—Leadership changesSource
May 12, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 30, 2026Leadership change: Ian Blackman appointed, Chief Financial Officer—Leadership changesSource

Onto Innovation Inc

At 5% or more3
Filings4
Latest filing2026-04-29

Onto Innovation Inc has 4 Schedule 13D or 13G filings on record since 2025-10-17. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.10.3%5,039,082SCHEDULE 13G/A, 2025-10-172025-09-30
Vanguard Portfolio Management5.53%2,751,547SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.23%2,602,830SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.4,872,45105,039,0820SCHEDULE 13G/A, 2025-10-17
Vanguard Portfolio Management8,52802,751,5470SCHEDULE 13G, 2026-04-29
Vanguard Capital Management379,97802,602,8300SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Onto Innovation Inc by CUSIP 683344105 and gives its principal executive office as 16 Jonspin Road, Wilmington, MA 01887 (SCHEDULE 13G, 2026-04-29).

FiledHolderPercentFiling
2025-10-17BlackRock, Inc.10.3%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.23%SCHEDULE 13G
2026-04-29Vanguard Portfolio Management5.53%SCHEDULE 13G
DateRecordFigureOur pageSource
November 17, 2025Acquired Semilab USA LLC$432.31MAcquisitionSource

Renovorx, Inc.

At 5% or more1
Filings5
Latest filing2026-04-27

Renovorx, Inc. has 5 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Orin Hirschman9.8%4,430,439SCHEDULE 13G/A, 2026-04-272026-03-31
AWM Investment Company, Inc.2.4%863,790SCHEDULE 13G/A, 2025-11-132025-09-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Orin Hirschman4,430,43904,430,4390SCHEDULE 13G/A, 2026-04-27
AIGH Capital Management LLC4,430,49304,430,4930SCHEDULE 13G/A, 2026-04-27
AWM Investment Company, Inc.863,7900863,7900SCHEDULE 13G/A, 2025-11-13

The latest filing identifies Renovorx, Inc. by CUSIP 75989R107 and gives its principal executive office as 2570 West El Camino Real, Suite 320, Mountain View, CA 94040 (SCHEDULE 13G/A, 2026-04-27).

FiledHolderPercentFiling
2025-08-14AWM Investment Company, Inc.5.1%SCHEDULE 13G/A
2025-11-10Orin Hirschman7.1%SCHEDULE 13G/A
2025-11-13AWM Investment Company, Inc.2.4%SCHEDULE 13G/A
2026-01-30Orin Hirschman7.1%SCHEDULE 13G/A
2026-04-27Orin Hirschman9.8%SCHEDULE 13G/A
DateRecordFigureOur pageSource
April 9, 2026Form D, private offering$10M soldForm D pageSource

Rockwell Automation Inc

At 5% or more3
Filings5
Latest filing2026-04-30

Rockwell Automation Inc has 5 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.9.1%10,222,503SCHEDULE 13G/A, 2026-04-242026-03-31
Vanguard Capital Management7.47%8,400,924SCHEDULE 13G, 2026-04-302026-03-31
Vanguard Portfolio Management5.21%5,860,884SCHEDULE 13G, 2026-04-292026-03-31
T. Rowe Price Associates, Inc.4.4%4,997,025SCHEDULE 13G/A, 2025-08-142025-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.9,494,309010,222,5030SCHEDULE 13G/A, 2026-04-24
Vanguard Capital Management1,099,09308,400,9240SCHEDULE 13G, 2026-04-30
Vanguard Portfolio Management15,15005,860,8840SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Rockwell Automation Inc by CUSIP 773903109 and gives its principal executive office as 1201 South Second Street, Milwaukee, WI 53204 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.4.4%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-24BlackRock, Inc.9.1%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.21%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.47%SCHEDULE 13G
DateRecordFigureOur pageSource
September 24, 2026Leadership change: Scott A. Genereux departs—Leadership changesSource
April 17, 2026Leadership change: David A. Zapico appointed, Director—Leadership changesSource

Sight Sciences, Inc.

At 5% or more1
Filings3
Latest filing2026-04-08

Sight Sciences, Inc. has 3 Schedule 13D or 13G filings on record since 2026-01-21. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.5.01%2,651,156SCHEDULE 13G, 2026-01-212025-12-31
Kck Ltd.2.7%1,438,094SCHEDULE 13G/A, 2026-04-082026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.2,614,20902,651,1560SCHEDULE 13G, 2026-01-21
Kck Ltd.01,438,09401,438,094SCHEDULE 13G/A, 2026-04-08
Nael Karim Kassar01,438,09401,438,094SCHEDULE 13G/A, 2026-04-08

The latest filing identifies Sight Sciences, Inc. by CUSIP 82657M105 and gives its principal executive office as 4040 CAMPBELL AVE, SUITE 100, MENLO PARK, CA 94025 (SCHEDULE 13G/A, 2026-04-08).

The ownership percentage reported is based on 54,005,984 shares of Common Stock outstanding as of February 26, 2026, as reported in the Issuer's Annual Report on Form 10-K filed with the SEC on March 4, 2026.Kck Ltd., SCHEDULE 13G/A, 2026-04-08
FiledHolderPercentFiling
2026-01-21BlackRock, Inc.5.01%SCHEDULE 13G
2026-02-04Kck Ltd.7%SCHEDULE 13G/A
2026-04-08Kck Ltd.2.7%SCHEDULE 13G/A
DateRecordFigureOur pageSource
August 10, 2026Leadership change: Kashif Rashid appointed, Chief Legal Officer—Leadership changesSource

Solventum Corp

At 5% or more3
Filings6
Latest filing2026-04-30

Solventum Corp has 6 Schedule 13D or 13G filings on record since 2025-08-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
3M Company14.8%25,569,190SCHEDULE 13G/A, 2025-08-182025-08-15
Independent Franchise Partners, LLP8.85%15,355,691SCHEDULE 13G/A, 2026-01-272025-12-31
Vanguard Capital Management6.27%10,875,310SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Independent Franchise Partners, LLP15,002,91391,65215,355,6910SCHEDULE 13G/A, 2026-01-27
Vanguard Capital Management1,273,361010,875,3100SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Solventum Corp by CUSIP 83444M101 and gives its principal executive office as 3M Center, Building 275-6W, St Paul, MN 55144 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-08-13Independent Franchise Partners, LLP5.86%SCHEDULE 13G
2025-08-183M Company14.8%SCHEDULE 13G/A
2025-11-13Independent Franchise Partners, LLP7.44%SCHEDULE 13G/A
2026-01-27Independent Franchise Partners, LLP8.85%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management6.27%SCHEDULE 13G
DateRecordFigureOur pageSource
July 20, 2026Leadership change: Neil Zieselman appointed, Chief Accounting Officer—Leadership changesSource

Teledyne Technologies Inc

At 5% or more3
Filings5
Latest filing2026-04-30

Teledyne Technologies Inc has 5 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.53%3,489,014SCHEDULE 13G, 2026-04-302026-03-31
T. Rowe Price Associates, Inc.6.7%3,126,015SCHEDULE 13G/A, 2025-08-142025-06-30
Vanguard Portfolio Management5.14%2,384,961SCHEDULE 13G, 2026-04-292026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management458,23203,489,0140SCHEDULE 13G, 2026-04-30
Vanguard Portfolio Management5,63302,384,9610SCHEDULE 13G, 2026-04-29
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Teledyne Technologies Inc by CUSIP 879360105 and gives its principal executive office as 1049 Camino Dos Rios, Thousand Oaks, CA 91360 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.6.7%SCHEDULE 13G/A
2026-01-30The Vanguard Group12.73%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.14%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.53%SCHEDULE 13G

Thermo Fisher Scientific Inc

At 5% or more1
Filings2
Latest filing2026-04-30

Thermo Fisher Scientific Inc has 2 Schedule 13D or 13G filings on record since 2026-03-27. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.53%28,008,822SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Capital Management3,728,006028,008,8220SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Thermo Fisher Scientific Inc by CUSIP 883556102 and gives its principal executive office as 168 3RD AVE, WALTHAM, MA 02451 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.53%SCHEDULE 13G
DateRecordFigureOur pageSource
October 30, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

TransMedics Group Inc

At 5% or more3
Filings4
Latest filing2026-04-30

TransMedics Group Inc has 4 Schedule 13D or 13G filings on record since 2025-07-18. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.14.6%4,955,262SCHEDULE 13G/A, 2025-07-182025-06-30
Vanguard Portfolio Management5.68%1,949,420SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.06%1,737,137SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.4,897,18904,955,2620SCHEDULE 13G/A, 2025-07-18
Vanguard Portfolio Management29,88501,949,4200SCHEDULE 13G, 2026-04-29
Vanguard Capital Management258,98501,737,1370SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies TransMedics Group Inc by CUSIP 89377M109 and gives its principal executive office as 200 Minuteman Road, Suite 302, Andover, MA 01810 (SCHEDULE 13G, 2026-04-30).

FiledHolderPercentFiling
2025-07-18BlackRock, Inc.14.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.68%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.06%SCHEDULE 13G
DateRecordFigureOur pageSource
September 10, 2026Leadership change: Fernando Araujo appointed, Chief Financial Officer, and 1 more—Leadership changesSource

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.